The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast

Abstract The identification of actionable biomarkers and development of targeted therapies have revolutionized the field of lung cancer treatment. In patients with advanced non-small cell lung cancer (NSCLC), biomarker testing can inform selection of effective targeted therapies as well as avoid the...

Full description

Bibliographic Details
Main Authors: Fred R. Hirsch, Chul Kim
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-03-01
Series:Oncology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40487-024-00271-w